ADAP and SKAP55 deficiency suppresses PD‐1 expression in CD8+ cytotoxic T lymphocytes for enhanced anti‐tumor immunotherapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1757-4684|7|6|754-769

ISSN： 1757-4676

Source： EMBO Molecular Medicine, Vol.7, Iss.6, 2015-06, pp. : 754-769

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A high‐throughput RNAi screen for detection of immune‐checkpoint molecules that mediate tumor resistance to cytotoxic T lymphocytes

By  

EMBO Molecular Medicine, Vol. 7, Iss. 4, 2015-04 ,pp. : 450-463

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long non‐coding RNA AGER‐1 functionally upregulates the innate immunity gene AGER and approximates its anti‐tumor effect in lung cancer

By  

Molecular Carcinogenesis, Vol. 57, Iss. 3, 2018-03 ,pp. : 305-318

John Wiley & Sons Inc

Access to resources Recommend Favorite

Circulating PD‐L1 in NSCLC patients and the correlation between the level of PD‐L1 expression and the clinical characteristics

By  

Thoracic Cancer, Vol. 6, Iss. 4, 2015-07 ,pp. : 534-538

John Wiley & Sons Inc

Access to resources Recommend Favorite

Co‐infection with Chikungunya virus alters trafficking of pathogenic CD8+ T cells into the brain and prevents Plasmodium‐induced neuropathology

By  

EMBO Molecular Medicine, Vol. 10, Iss. 1, 2018-01 ,pp. : 121-138

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pulmonary pleomorphic carcinoma with few PD‐1‐positive immune cells and regulatory T cells that showed a complete response to nivolumab

By  

Thoracic Cancer, Vol. 9, Iss. 1, 2018-01 ,pp. : 193-196

John Wiley & Sons Inc

Access to resources Recommend Favorite